SynCore Biotechnology Co Ltd (4192) - Total Liabilities

Latest as of September 2025: NT$14.88 Million TWD ≈ $468.77K USD

Based on the latest financial reports, SynCore Biotechnology Co Ltd (4192) has total liabilities worth NT$14.88 Million TWD (≈ $468.77K USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash efficiency ratio of SynCore Biotechnology Co Ltd to assess how effectively this company generates cash.

SynCore Biotechnology Co Ltd - Total Liabilities Trend (2015–2024)

This chart illustrates how SynCore Biotechnology Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check 4192 financial resilience to evaluate the company's liquid asset resilience ratio.

SynCore Biotechnology Co Ltd Competitors by Total Liabilities

The table below lists competitors of SynCore Biotechnology Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Jullundur Motor Agency (Delhi) Limited NSE:JMA	India	Rs707.50 Million
Giyani Metals Corp V:EMM	Canada	CA$40.22 Million
Global SM Tech Limited KQ:900070	Korea	₩35.90 Billion
Sintercom India Limited NSE:SINTERCOM	India	Rs968.38 Million
NEVADA LITHIUM RESOURCES F:87K	Germany	€216.98K
Galileo Mining Ltd AU:GAL	Australia	AU$540.25K
Advicenne PA:ALDVI	France	€30.73 Million

Liability Composition Analysis (2015–2024)

This chart breaks down SynCore Biotechnology Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is SynCore Biotechnology Co Ltd worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	15.34	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.06	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.05	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how SynCore Biotechnology Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for SynCore Biotechnology Co Ltd (2015–2024)

The table below shows the annual total liabilities of SynCore Biotechnology Co Ltd from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	NT$23.11 Million ≈ $728.19K	+8.89%
2023-12-31	NT$21.23 Million ≈ $668.74K	-88.69%
2022-12-31	NT$187.64 Million ≈ $5.91 Million	-50.82%
2021-12-31	NT$381.52 Million ≈ $12.02 Million	+7.95%
2020-12-31	NT$353.41 Million ≈ $11.13 Million	+132.75%
2019-12-31	NT$151.84 Million ≈ $4.78 Million	+54.77%
2018-12-31	NT$98.11 Million ≈ $3.09 Million	-21.68%
2017-12-31	NT$125.28 Million ≈ $3.95 Million	-15.61%
2016-12-31	NT$148.46 Million ≈ $4.68 Million	-19.52%
2015-12-31	NT$184.46 Million ≈ $5.81 Million	--

About SynCore Biotechnology Co Ltd

TWO:4192 Taiwan Biotechnology

Market Cap

$21.71 Million

NT$689.23 Million TWD

Market Cap Rank

#24789 Global

#1552 in Taiwan

Share Price

NT$19.60

Change (1 day)

-1.75%

52-Week Range

NT$19.55 - NT$30.35

All Time High

NT$537.12